Search Results 921-930 of 17963 for SARS-CoV-2
Immunogenicity and Safety of Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients with Hematologic Malignancies and ...
Last week, the first COVID-19 vaccine was approved for emergency authorization use in the United Kingdom. Meanwhile in the U.S., plans are being made to ...
The Vaccine Research Group at Mayo Clinic is researching rubella to better understand the virus and develop potential vaccines ... SARS-CoV-2 · Influenza ...
On Thursday, Oct. 7, Dr. Greg Vanichkachorn, a Mayo Clinic occupational medicine specialist, discussed how for some patients, post-COVID syndrome is ...
Stroke Features, Risk Factors, and Pathophysiology in SARS-CoV-2-Infected Patients. Mayo Clin Proc Innov Qual Outcomes. 2022 Apr; 6 (2):156-165 Epub 2022 Jan 21
Are your at-home COVID-19 tests expired or about to expired? Don't toss those tests. Learn more from a Mayo Clinic expert.
Millions of people around the world are coping with job loss caused by the coronavirus disease 2019 (COVID-19) pandemic. Whether it's temporary or permanent ...
The objectives of this study are to determine the prevalence of spike (S) protein antibodies in COVID-19 vaccinated individuals, to assess the role of age and ...
Scientists, health care providers and the public have gained new knowledge and understanding of infectious diseases and virus transmission, and COVID-19 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!